News & Updates

Intranasal oxytocin does not enhance social behaviour in children, adolescents with ASD
Intranasal oxytocin does not enhance social behaviour in children, adolescents with ASD
02 Dec 2021 byAudrey Abella

In children and adolescents with autism spectrum disorder (ASD), intranasal oxytocin did not improve social interaction or other measures of social function related to ASD, the phase II SOARS-B* trial suggests.

Intranasal oxytocin does not enhance social behaviour in children, adolescents with ASD
02 Dec 2021
Poorer mental health in people with multiple psychotic experiences
Poorer mental health in people with multiple psychotic experiences
01 Dec 2021
Depressive symptoms foretell HFpEF risk in late life
Depressive symptoms foretell HFpEF risk in late life
26 Nov 2021

A recent study has shown that depression predicts the risk of developing heart failure (HF) with preserved ejection fraction (HFpEF) in late life, and the greater the symptoms, the higher the risk.

Depressive symptoms foretell HFpEF risk in late life
26 Nov 2021
Depressive symptoms during internship drop, but depression still high
Depressive symptoms during internship drop, but depression still high
25 Nov 2021

Depression during physician training remains high, but the average increase in depressive symptoms associated with internship has declined from 2007 to 2019, results of a study have shown.

Depressive symptoms during internship drop, but depression still high
25 Nov 2021